These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"? Napoletano S; Basile G; Lo Faro AF; Negro F Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997 [TBL] [Abstract][Full Text] [Related]
3. Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe. Mounteney J; Giraudon I; Denissov G; Griffiths P Int J Drug Policy; 2015 Jul; 26(7):626-31. PubMed ID: 25976511 [TBL] [Abstract][Full Text] [Related]
4. The Rapid Escalation of Fentanyl in Illicit Drug Evidence in Allegheny County, Pennsylvania, 2010-2016. Creppage KE; Yohannan J; Williams K; Buchanich JM; Songer TJ; Wisniewski SR; Fabio A Public Health Rep; 2018; 133(2):142-146. PubMed ID: 29389251 [TBL] [Abstract][Full Text] [Related]
8. Killer fentanyl: is the fear justified? Fodale V; Mafrica F; Santamaria LB; Coleman JJ Expert Opin Drug Saf; 2008 May; 7(3):213-7. PubMed ID: 18462178 [TBL] [Abstract][Full Text] [Related]
9. A deadly trend in fentanyl fatalities (England, 1998-2017). Claridge H; Williams BD; Copeland CS Br J Clin Pharmacol; 2020 Mar; 86(3):437-444. PubMed ID: 31663152 [TBL] [Abstract][Full Text] [Related]
10. Fentanyl-associated illness among substance users - Fulton County, Georgia, 2015. Angela Parham M; Pomerleau AC; Peralta G; Drenzek CL; Edison LS Am J Emerg Med; 2018 Nov; 36(11):2115-2117. PubMed ID: 29625855 [No Abstract] [Full Text] [Related]
11. DARK Classics in Chemical Neuroscience: Fentanyl. Burns SM; Cunningham CW; Mercer SL ACS Chem Neurosci; 2018 Oct; 9(10):2428-2437. PubMed ID: 29894151 [TBL] [Abstract][Full Text] [Related]
12. Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse? Burns G; DeRienz RT; Baker DD; Casavant M; Spiller HA Clin Toxicol (Phila); 2016 Jun; 54(5):420-3. PubMed ID: 26999038 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl. Bilel S; Azevedo Neto J; Arfè R; Tirri M; Gaudio RM; Fantinati A; Bernardi T; Boccuto F; Marchetti B; Corli G; Serpelloni G; De-Giorgio F; Malfacini D; Trapella C; Calo' G; Marti M Neuropharmacology; 2022 May; 209():109020. PubMed ID: 35247453 [TBL] [Abstract][Full Text] [Related]
14. The fentanyl crisis. Jaimet K Can Nurse; 2017; 113(1):23-5. PubMed ID: 29236413 [No Abstract] [Full Text] [Related]
15. The fentanyl family: A distinguished medical history tainted by abuse. Raffa RB; Pergolizzi JV; LeQuang JA; Taylor R; ; Colucci S; Annabi MH J Clin Pharm Ther; 2018 Feb; 43(1):154-158. PubMed ID: 28980330 [TBL] [Abstract][Full Text] [Related]
16. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin. Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB; Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175 [TBL] [Abstract][Full Text] [Related]
17. Fentanyl shock: The changing geography of overdose in the United States. Zoorob M Int J Drug Policy; 2019 Aug; 70():40-46. PubMed ID: 31079029 [TBL] [Abstract][Full Text] [Related]
18. FDA confronts opioid addiction and overdose deaths. Furlow B Lancet Oncol; 2016 Mar; 17(3):e95. PubMed ID: 26877160 [No Abstract] [Full Text] [Related]
19. Opioids in the Frame of New Psychoactive Substances Network: A Complex Pharmacological and Toxicological Issue. Ventura L; Carvalho F; Dinis-Oliveira RJ Curr Mol Pharmacol; 2018; 11(2):97-108. PubMed ID: 28676005 [TBL] [Abstract][Full Text] [Related]
20. ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products. American College of Medical Toxicology J Med Toxicol; 2016 Jun; 12(2):211-2. PubMed ID: 26847376 [No Abstract] [Full Text] [Related] [Next] [New Search]